This study leveraged a nationwide, multicenter database of electronic health records (EHRs) of more than 118 million US patients to conduct rigorous target trial emulation in patients with type 2 diabetes to examine associations of semaglutide or tirzepatide with optic nerve and visual pathway disorders, including NAION
10.3390/ijms21134777 [DOI] [PMC free article] [PubMed] [Google Scholar] 243.Ding Y, Zhang B, Zhou K, Chen M, Wang M, Jia Y, et al
PlexusDx offers semaglutide and tirzepatide with upstream genetic context via the Precision Peptide Genetic Test, plus a flat $129 monthly Microdose GLP-1 Protocol for comparison
Table of Contents Introduction Semaglutide is a medication that has gained popularity in recent years, especially for its role in managing diabetes and promoting weight loss
By aligning visit structure with modern therapies, clinics can deliver better outcomes without longer appointments
Please consult your doctor to see if this treatment is right for you